Beijing Dikang Pharmaceutical Investment Management Co., Ltd.
UnverifiedHeadquarters: ChinaPrimary focus: Others
Based on a number of decellular patented technologies and the development and production platform for extra-cellular primary medical materials, the technology bottleneck of animal-based medical materials industrialization has been broken.The extracel
Introduction
Based on a number of decellular patented technologies and the development and production platform for extra-cellular primary medical materials, the technology bottleneck of animal-based medical materials industrialization has been broken.The extracellular substance produced is a class of natural materials with induced tissue repair and regeneration, which can be processed into biomembranes, sponges, gels and particles.It can be applied to all kinds of organ repairs, made into various surgical supplements, as a tissue filling material, for auxiliary cell treatment carriers.
Information
Categories
Related Companies
ChemExpoHub is a global directory for chemical, materials, and laboratory industry exhibitions, bringing together worldwide expo information and helping professionals stay updated with the latest events and trends. PREMIUM
ChemBusinessHub
Search chemical suppliers and manufacturers worldwide by company, product, CAS No., HS code, certification, product category, and region. PREMIUM
ChemTradeHub
Discover and trade chemicals worldwide with ChemTradeHub. Connect with verified suppliers, access detailed compound information, and streamline your chemical sourcing process.